Labcorp Holdings financials
$308.81−0.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B | $13.98B | $11.55B | $11.33B | $10.31B | $9.55B |
| Gross profit | $4.01B | $3.62B | $3.36B | $3.71B | $4.99B | $4.95B | $3.25B | $3.18B | $3.09B | $2.85B |
| Gross margin | 28.8% | 27.9% | 27.7% | 31.3% | 38.0% | 35.4% | 28.1% | 28.0% | 30.0% | 29.9% |
| Operating income | $1.38B | $1.09B | $725.6M | $1.44B | $3.05B | $2.45B | $1.33B | $1.33B | $1.31B | $1.27B |
| Net income | $876.5M | $746.0M | $418.0M | $1.28B | $2.38B | $1.56B | $823.8M | $883.7M | $1.23B | $711.8M |
| Net margin | 6.3% | 5.7% | 3.4% | 10.8% | 18.1% | 11.1% | 7.1% | 7.8% | 11.9% | 7.5% |
| Diluted EPS | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 | $15.88 | $8.35 | $8.61 | $11.81 | $6.82 |
| EBITDA | $2.20B | $1.78B | $1.70B | $2.29B | $3.81B | $3.57B | $1.96B | $1.93B | $1.91B | $1.83B |
| Operating cash flow | $1.64B | $1.59B | $1.33B | $1.96B | $3.11B | $2.14B | $1.44B | $1.31B | $1.50B | $1.20B |
| Free cash flow | $1.21B | $1.10B | $874.1M | $1.53B | $2.69B | $1.75B | $1.04B | $925.6M | $1.19B | $918.2M |
| Diluted shares | 83.8M | 84.4M | 87.6M | 91.6M | 97.5M | 98.0M | 98.6M | 102.6M | 103.9M | 104.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $532.3M | $1.52B | $536.8M | $320.6M | $1.47B | $1.32B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $5.65B | $6.41B | $5.14B | $5.43B | $5.51B | $5.89B |
| Total assets | $18.39B | $18.38B | $16.73B | $20.16B | $20.39B | $20.07B |
| Total liabilities | $9.76B | $10.31B | $8.83B | $10.04B | $10.09B | $10.61B |
| Shareholders' equity | $8.64B | $8.07B | $7.89B | $10.12B | $10.27B | $9.46B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology